Status:
TERMINATED
Effect of B. Braun Peripheral Advantage Program on Complications, Indwell Time and First Stick Success of PIVC Therapy
Lead Sponsor:
B. Braun Medical Inc.
Conditions:
Complications Associated With Device
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Single sequence clinical study designed to evaluate the effectiveness of B. Braun PA on improved clinical outcomes, indwell time and first stick success of PIVC using B. Braun Peripheral Advantage (PA...
Eligibility Criteria
Inclusion
- RNs must complete all of the required B. Braun trainings in Stage 2 in order to participate in Stages 3 and 4.
- Subjects must meet all of the following
- Male or female aged ≥18 years;
- The subject or the subject's LAR voluntarily agrees that the subject will participate in this study and is able to understand and sign the Informed Consent Form (ICF);
- Have a medical condition that requires a PIVC anticipated to last for at least 48 hours;
- Have intact skin at the site of insertion;
- If the patient has an existing IV in one arm he/she must have a viable contralateral arm for additional PIVC insertion.
Exclusion
- Subjects must not meet any of the following
Key Trial Info
Start Date :
January 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2021
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04048863
Start Date
January 24 2020
End Date
July 27 2021
Last Update
August 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
La Crosse, Wisconsin, United States, 54601